Venetoclax for treating refractory autoimmune hemolytic anemia in chronic lymphocytic leukemia: report of two cases in Spain

Haematologica. 2023 Aug 1;108(8):2261-2264. doi: 10.3324/haematol.2022.281850.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anemia, Hemolytic, Autoimmune* / complications
  • Anemia, Hemolytic, Autoimmune* / drug therapy
  • Bridged Bicyclo Compounds, Heterocyclic / therapeutic use
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell* / complications
  • Leukemia, Lymphocytic, Chronic, B-Cell* / drug therapy
  • Spain

Substances

  • venetoclax
  • Bridged Bicyclo Compounds, Heterocyclic

Grants and funding

Funding: PG-N has received a grant from AbbVie during the conduct of the study.